Synergistic Effect of Garcinol and Curcumin on Antiproliferative and Apoptotic Activity in Pancreatic Cancer Cells
Open Access
- 23 May 2012
- journal article
- research article
- Published by Hindawi Limited in Journal of Oncology
- Vol. 2012, 1-8
Abstract
Pancreatic cancer (PaCa) is a major health concern due to its aggressiveness and early metastasis. Current treatments for PaCa are limited by development of resistance against therapy. As an alternative strategy, we assessed the combinatorial effect of dietary compounds, garcinol and curcumin, on human PaCa cells (BxPC-3 and Panc-1). A significant (𝑃<0.05) dose-dependent reduction in cell viability and increase in apoptosis were observed in both cell lines as compared to untreated controls. A combination index (CI) value<1, for a two-way comparison of curcumin and garcinol, suggests synergism. The potency (Dm) of the combination of garcinol and curcumin was 2 to 10 fold that of the individual agents. This indicates that curcumin and garcinol in combination exhibit a high level of synergism, with enhanced bioactivity, thereby reducing the required effective dose required for each individually. This combinatorial strategy may hold promise in future development of therapies against PaCa.Keywords
This publication has 10 references indexed in Scilit:
- Garcinol Inhibits Cell Proliferation and Promotes Apoptosis in Pancreatic Adenocarcinoma CellsNutrition and Cancer, 2011
- Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF- KappaB signalingFrontiers in Bioscience-Elite, 2011
- Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?The AAPS Journal, 2009
- Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutionsScandinavian Journal of Gastroenterology, 2009
- Synergistic effects of multiple natural products in pancreatic cancer cellsLife Sciences, 2008
- Pancreatic cancer: Pathogenesis, prevention and treatmentToxicology and Applied Pharmacology, 2007
- Chemotherapeutic Potential of Curcumin for Colorectal CancerCurrent Pharmaceutical Design, 2002
- [Adjuvant concomitant chemotherapy in pancreatic cancer].1999
- [Descriptive epidemiology of cancer of the pancreas].1990
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984